MedTrace Logo

Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852

NCT03381703 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-12-22

No results posted yet for this study

Summary

This study investigates the absorption, metabolism, and excretion and the absolute bioavailability of YH12852 in healthy male subjects

Conditions

Interventions

DRUG

YH12852

YH12852 administration

DRUG

14C-labeled YH12852

14C-labeled YH12852 administration

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Howard Lee, MD., PhD · Seoul National University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-16
Primary Completion
2017-03-29
Completion
2017-03-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03381703 on ClinicalTrials.gov